Cargando…
High-throughput sequencing technology facilitates the discovery of novel biomarkers for antiphospholipid syndrome
Antiphospholipid syndrome (APS) is characterized by arterial and venous thrombosis and/or morbid pregnancy, accompanied by persistent antiphospholipid antibody (aPL) positivity. However, due to the complex pathogenesis of APS and the large individual differences in the expression of aPL profiles of...
Autores principales: | Liu, Qi, Yang, Shuo, Tan, Yuan, Cui, Liyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10235516/ https://www.ncbi.nlm.nih.gov/pubmed/37275905 http://dx.doi.org/10.3389/fimmu.2023.1128245 |
Ejemplares similares
-
Pyroptosis-triggered pathogenesis: New insights on antiphospholipid syndrome
por: Tan, Yuan, et al.
Publicado: (2023) -
Urine Proteomics Differentiate Primary Thrombotic Antiphospholipid Syndrome From Obstetric Antiphospholipid Syndrome
por: Zhou, Zhuochao, et al.
Publicado: (2021) -
Exosome-Contained APOH Associated With Antiphospholipid Syndrome
por: Tan, Yuan, et al.
Publicado: (2021) -
Non-criteria antiphospholipid antibodies in antiphospholipid syndrome: Diagnostic value added
por: Liu, Xiangjun, et al.
Publicado: (2022) -
New Biomarkers for Atherothrombosis in Antiphospholipid Syndrome: Genomics and Epigenetics Approaches
por: Lopez-Pedrera, Chary, et al.
Publicado: (2019)